Impingement syndrome refers to a painful condition that occurs when the tendons of the rotator cuff get squeezed or impinged between the head of the humerus and the edge of the acromion. Some of the common symptoms include shoulder pain that gets worse with overhead activity or lifting the arm, shoulder weakness, and decreased range of motion. Impingement syndrome is often caused due to injuries from repetitive overhead movements or age-related wear and tear. There is a growing demand for various therapies and medications that provide relief from shoulder pain and help in improving mobility. The global Impingement Syndrome Market is estimated to be valued at US$ 2,173.5 Mn in 2023 and is expected to exhibit a CAGR of 7.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends driving the impingement syndrome market growth is the increasing prevalence of shoulder pain and related conditions globally. As per estimates, over 5 million people in the U.S. alone are affected by shoulder impingement annually. The risk is higher among individuals involved in overhead sports and occupational tasks. With changing lifestyles and rising sedentary jobs, the incidence of impingement syndrome and associated rotator cuff tears is rising significantly. Moreover, the growing geriatric population also contributes to the increasing burden of shoulder disorders owing to age-related degenerative changes in tendons and joints. All these factors collectively are expected to propel the demand for advanced therapies for impingement syndrome treatment over the forecast period.
Segment Analysis
The global impingement syndrome market can be segmented into treatment type and end user. By treatment type, the physiotherapy segment is expected to dominate the market during the forecast period. Physiotherapy is generally the first line of treatment for impingement syndrome and includes modalities like ultrasound, heat treatment, ice therapy etc. that provides relief from pain and swelling. By end user, hospitals & clinics are likely to hold a significant share as they are the primary points of contact for people seeking medical attention and treatment.
Key Takeaways
The global impingement syndrome market is expected to witness high growth during the forecast period of 2023-2030. The rising incidence of shoulder injuries and associated conditions is driving the market.
Regional analysis: North America is projected to dominate the global market during the forecast period. This is attributed to factors such as rising awareness regarding impingement syndrome, developed healthcare infrastructure, and increasing healthcare spending in the region. Moreover, presence of key players in countries like the U.S. is also boosting the market in North America.
Key players operating in the impingement syndrome market are Thermo Fisher Scientific Inc., GE Healthcare, Merck KGaA, Bio-Rad Laboratories, Inc., Lonza, Abcam plc, PerkinElmer Inc., Bio-Techne, BioVision Inc., Cell Signaling Technology, Inc., and Geno Technology Inc. Thermo Fisher Scientific Inc. offers a wide range of solutions for cell culture and cell-based assays used in researching impingement syndrome.
No comments:
Post a Comment